8.20 USD
↗ 0.04 (0.49%)AT CLOSE (03:59 PM EDT)
Shares of Atrium Therapeutics, Inc. Common Stock (RNA) are trading at $8.20. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Oct 23, 2026.